Latest Financial Position News

Lotus Resources has achieved a key milestone at its Kayelekera Uranium Mine with the first high-grade ore delivered to the ROM pad, setting the stage for steady-state production targeted in early 2026. The company has also secured multiple sulphuric acid suppliers and is on track to commission its acid plant to ease supply constraints and reduce costs.

S2 Resources has completed the sale of its Fosterville exploration licence to Agnico Eagle for A$17 million, significantly strengthening its cash position and enabling a renewed focus on exploration projects in New South Wales and Western Australia.

TrivarX has received $3.5 million in second-tranche placement funding, enabling advancement of its innovative Stabl-Im technology for early, non-invasive brain tumour detection. The funding supports manufacturing scale-up and regulatory preparations ahead of a planned Phase 1 clinical trial in 2026.

Altamin Limited has completed a $1.003 million placement, bolstering its financial position to progress key projects in Italy amid ongoing permitting and partnership efforts.

Reece Limited has increased its on-market share buyback target by $50 million, raising the total to $85 million as part of its disciplined capital management strategy.

Midas Minerals has completed its acquisition of the Otavi Copper Project in Namibia, initiating multiple drilling programs across high-grade deposits and securing strong funding to drive exploration in 2026.

Waypoint REIT has secured a decade-long lease extension with Viva Energy Australia on 21 sites, boosting rental income by over 12% from August 2026. The REIT also strengthens its financial footing through key refinancing moves.

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

Strata Minerals Limited has successfully completed the first tranche of its $1.175 million capital raising, issuing over 55 million shares to investors. The company now awaits shareholder approval to complete the remaining funding.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.

Stockland has announced an estimated ordinary dividend of AUD 0.09 per security for the six months ending December 2025, payable in February 2026, alongside a Dividend Reinvestment Plan offering a 1% discount.

FAR Limited has agreed to promptly pay Woodside Energy a $6 million claim related to the 2021 sale of its interest in the RSSD Project, with a potential refund if Woodside recovers disputed costs from Senegal authorities.